Brilaroxazinum

Brilaroxazinum Uses, Dosage, Side Effects, Food Interaction and all others data.

Brilaroxazinum (RP5063) is an investigational atypical antipsychotic which is under development by Reviva Pharmaceuticals for the treatment of schizophrenia and schizoaffective disorder. Reviva Pharmaceuticals also intends to investigate RP5063 for the treatment of bipolar disorder, major depressive disorder, psychosis/agitation associated with Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder (ADD/ADHD), and autism. As of May 2015, it is in phase III clinical trials for schizophrenia.

Table Of contents

• Brilaroxazinum
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Brilaroxazinum
Generic	Brilaroxazine
Brilaroxazine Other Names	Brilaroxazina, Brilaroxazine, Brilaroxazinum
Type
Formula	C22H25Cl2N3O3
Weight	Average: 450.36 Monoisotopic: 449.1272971
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for the treatment of schizophrenia and schizoaffective disorder.

Innovators Monograph

You find simplified version here Brilaroxazinum